4[1]Lauts V,La Fata V,Plutzky J,et al.Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.Circulation,1998,97:1129-1135.
5[2]Walter DH,Ritting K,Bahlmann FH.Statin therapy accelerates reendothelization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.Circulation,2002,105:3017-3024.
6[3]Rauch U,Osende JI,Chesebro JH,et al.Statins and cardiovascular diseases:the multiple effect of lipid-lowering therapy by statins.Atherosclerosis,2000,153:181-189.
7[4]Ortego M,Bustos C,Hemanudez-Presa MA,et al.Atorvastatin reduces NF-γB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.Atherosclerosis,1999,147:253-261.
8[6]Ozmen J,Bobryshev YV,Lord RS,et al.Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia.Histol Histopathol,2002,17:223-237.
9[8]Liang C,Jia Q,Luo Y,et al.Pravastatin inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells by upregulating PPAR gamma:a new immunomodulatory mechanism of statins.Am J Cardiol,2004,94:E107.
10[10]Chmielewski M,Zdrojewski Z,Rutkowski B.Benefits and menaces related to the use of statins in patients after renal transplantation.Ann Transplant,2002,7:6-10.
